International legal practice Osborne Clarke has advised the Vendors, including award-winning growth investor Synova Capital on the sale of 4Ways to ECI Partners, a leading growth-focused, UK mid-market private equity firm.
Osborne Clarke previously acted for Synova on the original buyout of 4Ways in 2015.
Headquartered in Hertfordshire, 4Ways is a leading, rapidly growing tele-diagnostics company. 4Ways operates a full 24 hours a day, 365 days a year tech-enabled service, providing routine, out-of-hours and specialist clinical reporting on diagnostic images which help hospitals, CCGs and other healthcare providers to deliver high quality and efficient care to their patients.
Following its investment in 4Ways in 2015, Synova supported the business and its CEO, Ajay Chadha, with significant investment in talent and technology, which enabled the business to scale rapidly, continuously improve quality and to develop new service lines.
The Osborne Clarke team was led by Partner Alisdair Livingstone, with support from Associate Director Chris Yeo, Senior Associate James Taylor, and Associate Katharine Ramsay (corporate), Partner David Nisbet and Associate Alistair Godwin (tax), Partner Kevin Barrow (contingent workforce), Partner Tom Bussy (banking) and Associate Rhiannon Jones (employee incentives).
Osborne Clarke’s corporate team is considered the go-to practice for many businesses in the life sciences and healthcare sector, working with leading global businesses, fast-growth start-ups and market challengers. The team advises at every stage of company development across all corporate areas, from equity and debt fundraising to M&A, IPOs and JVs.
Corporate communications and press contacts
Connect with one of our experts
